Melanoma cells can develop different approaches to evade immune surveillance12 including: (1) upregulation of the cell surface expression of T cell inhibitory molecules (e.g., PD-L1, TIM3, etc44,45). This evidence concerns the gene HAVCR2 and melanoma.